PRF Technologies (PRFX) Cash & Equivalents (2019 - 2026)
PRF Technologies (PRFX) reported Cash & Equivalents of $8.53 million for the quarter ended Jun 30, 2026, up 99.6% from $4.27 million a year earlier.
Powered by 
Analysis
PRF Technologies (PRFX) Cash & Equivalents (2019 - 2026) Analysis & Trends
As of Dec 31, 2025, PRF Technologies posted Cash & Equivalents of $3.13 million, down 26.7% from the prior year.
- Cash & Equivalents has declined for three consecutive years, with a five-year compound annual growth rate of -27.6% (years ended Dec 2020 to Dec 2025).
- By year, Cash & Equivalents came in at $4.26 million in the year ended Dec 31, 2024 (-47.0%), $8.04 million in the year ended Dec 31, 2023 (-51.5%), $16.57 million in the year ended Dec 31, 2022 (unchanged) and $16.57 million in the year ended Dec 31, 2021 (+5.6%).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Cash & Equivalents since the quarter ended Sep 30, 2022.
- Year over year, Cash & Equivalents gained in two of the last four quarters, with growth averaging 19.9%.
- The high point for year-over-year Cash & Equivalents in five years was the quarter ended Jun 30, 2026 (growth of 99.6%); the low point was the quarter ended Dec 31, 2022 (a decline of 75.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | PRF Technologies | 466,605.35 | -22.95 Mn | - | 8.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.53 Mn |
| Dec 31, 2025 | 3.13 Mn |
| Jun 30, 2025 | 3.48 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Sep 30, 2023 | 7.55 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 8.14 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 6.92 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 15.42 Mn |
| Dec 31, 2021 | 16.54 Mn |
| Sep 30, 2021 | 18.34 Mn |
| Jun 30, 2021 | 17.79 Mn |
| Mar 31, 2021 | 19.42 Mn |
| Dec 31, 2020 | 15.68 Mn |
| Jun 30, 2020 | 544,000.00 |
API Access
PRF Technologies Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();